Wellington Management Group LLP reduced its stake in Aemetis, Inc. (NASDAQ:AMTX – Free Report) by 66.2% during the 4th quarter, HoldingsChannel.com reports. The fund owned 26,012 shares of the specialty chemicals company’s stock after selling 51,044 shares during the quarter. Wellington Management Group LLP’s holdings in Aemetis were worth $70,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. Clear Harbor Asset Management LLC acquired a new position in shares of Aemetis in the fourth quarter valued at approximately $44,000. Intech Investment Management LLC purchased a new position in Aemetis in the 4th quarter valued at approximately $46,000. FMR LLC grew its stake in shares of Aemetis by 68.2% in the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after acquiring an additional 9,137 shares in the last quarter. SG Americas Securities LLC acquired a new position in shares of Aemetis in the fourth quarter worth $87,000. Finally, Barclays PLC increased its position in shares of Aemetis by 274.6% during the third quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock worth $109,000 after acquiring an additional 34,816 shares during the period. Hedge funds and other institutional investors own 27.02% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research firms recently issued reports on AMTX. Ascendiant Capital Markets lifted their target price on Aemetis from $18.00 to $19.00 and gave the company a “buy” rating in a report on Monday, March 17th. HC Wainwright reiterated a “buy” rating and issued a $28.00 price objective on shares of Aemetis in a research note on Friday, March 14th. Finally, StockNews.com upgraded shares of Aemetis to a “sell” rating in a research note on Wednesday, February 5th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, Aemetis currently has an average rating of “Hold” and an average target price of $14.56.
Aemetis Price Performance
NASDAQ:AMTX opened at $1.43 on Wednesday. Aemetis, Inc. has a 12 month low of $1.40 and a 12 month high of $4.73. The firm has a market capitalization of $76.25 million, a PE ratio of -0.63 and a beta of 1.30. The business’s fifty day moving average price is $1.82 and its 200 day moving average price is $2.57.
About Aemetis
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
Recommended Stories
- Five stocks we like better than Aemetis
- Find and Profitably Trade Stocks at 52-Week Lows
- Beware of BigBear.ai: Insiders Are Selling—Should You?
- High Flyers: 3 Natural Gas Stocks for March 2022
- CrowdStrike Stock is a Buy as Cyberthreat Environment Expands
- How to Invest in Insurance Companies: A Guide
- Congress! Who Traded What During the Tariff-Induced Meltdown
Want to see what other hedge funds are holding AMTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aemetis, Inc. (NASDAQ:AMTX – Free Report).
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.